tiprankstipranks
Calliditas Therapeutics (CALT)
NASDAQ:CALT

Calliditas Therapeutics (CALT) Cash flow

120 Followers

Calliditas Therapeutics Cash Flow

CALT's free cash flow for Q4 2023 was kr―. For the 2023 fiscal year, CALT's free cash flow was decreased by kr-133.58M and operating cash flow was kr―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
kr -349.96Mkr -434.65Mkr -311.35Mkr -461.59Mkr -309.18Mkr -71.01M
Investing Cash Flow
kr -1.03Mkr -13.74Mkr -5.14Mkr -24.34Mkr -172.61Mkr -18.07M
Financing Cash Flow
kr 233.30Mkr 199.65Mkr 575.99Mkr 435.16Mkr 768.56Mkr 198.84M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
kr 1.58Bkr 973.73Mkr 1.58Bkr 1.40Bkr 996.30Mkr 753.54M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
---kr 324.00Mkr 891.39Mkr 210.32M
Issuance Of Debt
kr 236.46Mkr 199.65Mkr 480.87Mkr 179.09Mkr 0.00-
Repayment Of Debt
kr -5.10Mkr -763.24Mkr -10.88Mkr -20.43Mkr -3.97Mkr -1.65M
Free Cash Flow
kr -349.96Mkr -447.44Mkr -313.87Mkr -484.24Mkr -309.18Mkr -87.19M
Domestic Sales
------
Foreign Sales
------
Currency in SEK

Calliditas Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis